Cross-reactivity of the CEDIA buprenorphine assay in drugs-of-abuse screening: influence of dose and metabolites of opioids.

about

Cross-reactivity of the CEDIA buprenorphine assay in drugs-of-abuse screening: influence of dose and metabolites of opioids.

Item

http://www.wikidata.org/entity/Q42097867

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Cross-reactivity of the CEDIA ...... se and metabolites of opioids.

@en

Cross-reactivity of the CEDIA ...... se and metabolites of opioids.

@nl

type

Item

label

Cross-reactivity of the CEDIA ...... se and metabolites of opioids.

@en

Cross-reactivity of the CEDIA ...... se and metabolites of opioids.

@nl

prefLabel

Cross-reactivity of the CEDIA ...... se and metabolites of opioids.

@en

Cross-reactivity of the CEDIA ...... se and metabolites of opioids.

@nl

P1476

Cross-reactivity of the CEDIA ...... se and metabolites of opioids.

@en

P2093

Bettina Riedel

http://www.w3.org/2001/XMLSchema#string

Jan Schjøtt

http://www.w3.org/2001/XMLSchema#string

Kjell O Fossan

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine

High-performance liquid chromatographic study of codeine, norcodeine, and morphine as indicators of codeine ingestion.

Interindividual and interethnic differences in the demethylation and glucuronidation of codeine.

Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review.

Position of immunological techniques in screening in clinical toxicology.

Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine.

False-positive interferences of common urine drug screen immunoassays: a review.

A new highly specific buprenorphine immunoassay for monitoring buprenorphine compliance and abuse.

Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011.

Urinary concentrations of codeine and morphine after the administration of different codeine preparations in relation to doping analysis.

P304

131-139

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/SAR.S88935

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jon Andsnes Berg

P577

2015-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26604854

http://www.w3.org/2001/XMLSchema#string

P921

drug screening

P932

4630205

http://www.w3.org/2001/XMLSchema#string